Kampanjeplan Monte Rosa Therapeutics, Inc.
Avansert tidsplan
Enkel graf
Om selskapet
Monte Rosa Therapeutics, Inc., биофармацевтическая компания, занимается разработкой новых прецизионных препаратов с малыми молекулами, которые используют естественные механизмы организма для избирательного разложения терапевтически значимых белков. Он разрабатывает оральный молекулярный деструктор клея для GSPT1, фактора терминации трансляции и дегрон-содержащего белка для лечения рака, вызванного Myc. flere detaljerEBITDA | -0.0076 |
---|---|
EV/EBITDA | 0.686 |
IPO date | 2021-06-24 |
ISIN | US61225M1027 |
Industry | Biotechnology |
P/BV | 2.73 |
P/E | 1.74 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | http://www.monterosatx.com |
Цена ао | 6.36 |
Число акций ао | 0.0514 млрд |
Prisendring per dag: | +3.12% (7.05) |
---|---|
Prisendring per uke: | +11.67% (6.51) |
Prisendring per måned: | -15.47% (8.6) |
Prisendring over 3 måneder: | +35.63% (5.36) |
Prisendring over seks måneder: | +84.52% (3.94) |
Prisendring per år: | +22.6% (5.93) |
Prisendring over 3 år: | -65.22% (20.9) |
Prisendring over 5 år: | 0% (7.27) |
Prisendring over 10 år: | 0% (7.27) |
Prisendring siden begynnelsen av året: | +3.41% (7.03) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Citadel Advisors Llc | 980 | 1.94 |
NEA Management Company, LLC | 8 | 15.23 |
FMR, LLC | 5 | 10.57 |
Price (T.Rowe) Associates Inc | 5 | 10.09 |
Baker Brothers Advisors, LLC | 5 | 9.73 |
Avoro Capital Advisors LLC | 5 | 8.98 |
Blackrock Inc. | 2 | 4.57 |
Vanguard Group Inc | 2 | 3.24 |
Aisling Capital Management LP | 1 | 2.91 |
Alphabet Inc. | 1 | 2.9 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
Range Cancer Therapeutics ETF | 1.33526 | 47.24 | 0.11955 |
iShares Micro-Cap ETF | 0.06772 | 13.79 | 1.54048 |
Avantis U.S Small Cap Equity ETF | 0.02576 | 27.77 | 1.68271 |
Vanguard Russell 2000 ETF | 0.01 | 14.37 | 1.48801 |
Schwab U.S. Small-Cap ETF | 0.00652 | 13.35 | 1.51433 |
ProShares UltraPro Russell2000 | 0.00427 | 89.82 | 1.47873 |
Dimensional U.S. Targeted Value ETF | 0.0018 | 26.01 | 1.93487 |
ProShares Hedge Replication ETF | 0.00111 | 5.92 | 1.47892 |
iShares Russell 3000 ETF | 0.00062 | 23.61 | 1.43482 |
Dimensional US Core Equity Market ETF | 0.00034 | 30.98 | 1.40618 |
Schwab U.S. Broad Market ETF | 0.00029 | 23.7 | 1.43354 |
Avantis U.S. Equity ETF | 0.00028 | 20.45 | 1.59151 |
Dimensional U.S. Equity ETF | 0.00019 | 31.53 | 1.3557 |
Dimensional U.S. Core Equity 2 ETF | 0.00013 | 30.76 | 1.47098 |
Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Dr. Markus Warmuth M.D. | President, CEO & Director | 901.35k | 1971 (54 år) |
Ms. Jennifer Champoux | Chief Operating Officer | N/A | |
Dr. Sharon Townson Ph.D. | Chief Scientific Officer | N/A | 1975 (50 år) |
Dr. John C. Castle Ph.D. | Chief Data & Information Officer | N/A | 1971 (54 år) |
Dr. Filip Janku M.D., Ph.D. | Chief Medical Officer | 658.66k | 1974 (51 år) |
Mr. Philip Nickson J.D., Ph.D. | Chief Business & Legal Officer | N/A | 1979 (46 år) |
Mr. Magnus Walter DPHIL | Senior Vice President of Drug Discovery | N/A | |
Mr. Edmund Dunn | Vice President & Corporate Controller | N/A | 1966 (59 år) |
Mr. Andrew Funderburk | Senior VP and Head of IR & Strategic Finance | N/A |
Adresse: United States, Boston, MA , 645 Summer Street - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.monterosatx.com
Nettsted: http://www.monterosatx.com